BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10449609)

  • 1. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
    Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
    Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening programme in Finland.
    Anttila A; Nieminen P
    Eur J Cancer; 2000 Nov; 36(17):2209-14. PubMed ID: 11072206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population.
    Aareleid T; Pukkala E; Thomson H; Hakama M
    Eur J Cancer; 1993; 29A(5):745-9. PubMed ID: 8471334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods.
    Anttila A; Nieminen P
    Coll Antropol; 2007 Apr; 31 Suppl 2():17-22. PubMed ID: 17600933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
    Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
    Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
    Nieminen P; Hakama M; Tarkkanen J; Anttila A
    Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screening programme for cervical cancer that worked.
    Hakama M; Louhivuori K
    Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
    Nieminen P; Kallio M; Anttila A; Hakama M
    Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
    Walker JJ; Brewster D; Gould A; Raab GM
    Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of population screening for carcinoma of the uterine cervix in Finland.
    Hakama M
    Maturitas; 1985 May; 7(1):3-10. PubMed ID: 4021826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
    Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
    Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the National Cervical Cancer Screening Programme in Singapore.
    Jin AZ; Louange EC; Chow KY; Fock CW
    Singapore Med J; 2013 Feb; 54(2):96-101. PubMed ID: 23462834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.